DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2199299/thermo-fisher-tmo-to-allocate-ifa-testing-kits-with-new-pact?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2199299 Dec 18, 2023 - Thermo Fisher (TMO) will continue to meet the evolving needs of laboratories and healthcare professionals by expanding its immunology product portfolio of EliA autoimmune diagnostics. 0

https://www.zacks.com/stock/news/2205062/thermo-fisher-tmo-end-markets-drive-growth-amid-macro-woes?cid=CS-ZC-FT-analyst_blog|zer_report_update-2205062 Jan 03, 2024 - In the academic and government end markets, Thermo Fisher (TMO) is delivering strong growth in the electron microscopy, chromatography and mass spectrometry businesses. 0

https://www.zacks.com/stock/news/2205808/select-medical-sem-unveils-separation-plan-for-concentra?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2205808 Jan 04, 2024 - Select Medical (SEM) intends to separate its Concentra business in a bid to enhance shareholder value and boost growth prospects of strategically prioritized areas. 0

https://www.zacks.com/commentary/2221807/earnings-season-scorecard-and-analyst-reports-for-thermo-fisher-philip-morris-general-dynamics?cid=CS-ZC-FT-research_daily-2221807 Feb 06, 2024 - Today's Research Daily features the real-time earnings season scorecard and updated analyst reports on Thermo Fisher (TMO), Philip Morris International (PM) and General Dynamics (GD). 0

https://www.zacks.com/stock/news/2238707/thermo-fisher-tmo-unveils-corevitas-clinical-registry-in-gpp?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2238707 Mar 11, 2024 - Thermo Fisher's (TMO) new CorEvitas clinical registry addresses an unmet need for real-world evidence related to the clinical and patient-reported outcomes of patients with GPP. 0

https://www.zacks.com/commentary/2242883/top-analyst-reports-for-mastercard-abbvie-salesforce?cid=CS-ZC-FT-research_daily-2242883 Mar 19, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Mastercard Incorporated (MA), AbbVie Inc. (ABBV) and Salesforce, Inc. (CRM). 0

https://www.zacks.com/stock/news/2243769/thermo-fisher-scientific-tmo-stock-declines-while-market-improves-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2243769 Mar 20, 2024 - In the closing of the recent trading day, Thermo Fisher Scientific (TMO) stood at $580.05, denoting a -0.46% change from the preceding trading day. 0

https://www.zacks.com/stock/news/2257894/tmo-vs-idxx-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2257894 Apr 18, 2024 - TMO vs. IDXX: Which Stock Is the Better Value Option? 0